儿童突发性聋的临床特征及预后相关因素分析

目的 分析儿童突发性聋的临床特征、疗效及影响预后的相关因素,为临床治疗及预后评估提供依据。 方法 收集2010年1月至2017年10月就诊的67例突发性聋患儿临床资料,对其临床特征及治疗效果进行回顾性分析,同时根据疗效将患者分为总体有效组(36例)及无效组(31例),采用单因素及多因素分析的方法分析患者的性别、年龄、病程、初诊听阈、是否伴发耳鸣、眩晕、病毒感染史、发病季节和听力曲线类型对预后的影响。 结果 儿童突聋患者中64.18%在春冬季发病,其就诊时听阈为(76.62±25.97)dB HL,耳鸣及眩晕伴发率分别为70.15%和61.19%,病毒感染率为19.40%,听力曲线中10.44%为低频下降型、2.99%为高频下降型、34.33%为平坦型及52.24%为全聋型。经治疗后,患者听阈为(60.41±31.52)dB HL,总体有效率为53.73%,其中痊愈率、显效率及有效率分别为20.90%、16.42%和16.42%。多因素分析结果显示,初诊听阈越高及听力曲线为全聋型,预后越差(P均<0.05);伴有病毒感染的非全聋型患者预后较好(P<0.05)。 结论 儿童突发性聋患者病毒感染率较高且大部分在春冬季发病,就诊时听力损失较重并常伴有耳鸣及眩晕,其听力曲线以平坦型及全聋型为主。就诊时听力损伤程度轻、伴有病毒感染的非全聋型患者预后较好。     

尿毒症合并突发性聋患者的临床特征及预后

目的 分析尿毒症合并突发性聋(突聋)患者的临床特征及预后.方法 收集2015年1月-2019年12月在会理县人民医院治疗的尿毒症合并突聋患者29例(30耳),平均初诊听阈值为(62.33±13.68)dB HL;17耳(56.67％)伴耳鸣,8耳(26.67％)伴眩晕;9耳(30.00％)为平坦型,13耳(43.33％...     

儿童及成人突发性聋预后的对比分析

目的对比分析儿童及成人突发性聋预后的相关因素,为临床实践及患者预后评估提供依据。方法回顾性分析2008年1月~2016年12月住院治疗的237例（258耳）突发性聋患者的临床资料,其中儿童突发性聋患者（儿童组）26例（29耳）,成人突发性聋患者（成人组）211例（229耳）,采用单因素及多因素分析的方法对比分析两组突发性聋患者的年龄、性别、耳侧、初诊时间、就诊听阈、听力曲线、有否伴有耳鸣、眩晕及耳闷等因素对预后的影响。结果儿童突发性聋患者人数占总人数的11.0%;儿童组就诊听阈平均为（88.7±15.8）dB,高于成人组［（71.8±23.6）dB,(P＜0.05)］;儿童组听力曲线为全聋型的占69.0%,高于成人组（44.5%,P＜0.05）;经治疗后,儿童组的总体有效率为51.7%,成人组总体有效率为45.4%,两者差异无统计学意义（P＞0.05）。对儿童组预后的相关因素分析显示就诊听阈及伴发眩晕对疗效的影响具有统计学意义(P＜0.05);成人组中,初诊时间、就诊听阈及伴发眩晕对疗效的影响具有统计学意义（P<0.05）。结论儿童突发性聋患者就诊时听力损失较成人重,但治疗后两者总体有效率无明显差异（P>0.05）;儿童及成人突发性聋患者中听力损失程度越轻且不伴发眩晕者预后较好;就诊时间越早越有利于成人突发性聋患者的预后;而年龄、性别、耳侧以及是否伴发耳鸣、耳闷对儿童及成人突发性聋的预后无明显影响。     

全聋型突发性聋患者的预后及相关因素分析北大核心CSCD

目的分析全聋型突发性聋的临床特征及影响预后的因素,为该类型突聋的治疗及预后评估提供参考。方法回顾性分析2012年1月到2017年1月住院治疗的98例(98耳)全聋型突发性聋患者(250~8 000 Hz平均听阈94.94±8.30HL)的临床资料,根据疗效将患者分为有效组(34例)及无效组(64例),采用单因素及多因素分析的方法分析患者的性别、耳侧、年龄、病程、初诊听阈,是否伴发耳鸣、眩晕及耳闷胀感,是否有高血压、糖尿病史及鼓室注药、纤溶酶溶栓等多种因素对预后的影响。结果治疗后患者平均听阈为70.79±10.13dB HL,痊愈2耳、显效21耳、有效11耳,无效64耳,总有效率为34.69%(34/98),其中痊愈率、显效率及有效率分别为2.04%、21.43%和11.22%。多因素分析有效组和无效组上述各因素与疗效关系结果显示,初诊听阈越高,预后越差(P<0.05);伴发眩晕不利于患者的预后(P<0.05);给予鼓室注药及纤溶酶溶栓治疗有利于患者的预后(P<0.05)。结论全聋型突发性聋就诊时听力损失程度越轻、不伴发眩晕、鼓室注药及纤溶酶溶栓治疗的患者预后较好;积极治疗后,仍有好转甚至痊愈的可能。     

伴和不伴眩晕突聋患者疗效比较

目的观察伴和不伴眩晕突聋患者的疗效差异。方法选取2008～2010年收治并随诊1年后的突聋病例为研究对象,其中不伴眩晕突聋患者43例,伴眩晕突聋患者53例,两组患者均给予能量合剂及银杏叶提取物静脉滴注,1次/天;甲钴胺注射液0.5mg、地塞米松15mg加入5%葡萄糖250ml静脉滴注,1次/天,连用3天,若有效再用2天后停用激素;巴曲酶5BU加入0.9%氯化钠注射液静脉滴注,隔日一次,用3次,比较两组疗效。结果治疗前伴眩晕突聋组平均纯音听阈(58.43±19.31dB HL)与不伴眩晕组(58.64±20.81dB HL)差异无统计学意义(P>0.05),治疗后不伴眩晕突聋组的平均听阈(36.03±20.85dB HL)明显低于伴眩晕突聋组(40.12±22.21dB HL)(P<0.05)。伴眩晕突聋组总有效率为66.04%(35/53),不伴眩晕突聋组总有效率为55.81%(24/43),两组总有效率差异无统计学意义。随访一年,不伴眩晕突聋组和伴眩晕突聋组都有所好转,两组总好转率差异无统计学意义(P>0.05)。结论本组患者中,伴和不伴眩晕突聋者总效率差异无统计学意义,但治疗后伴眩晕突聋组听阈下降不如不伴眩晕组。     

儿童突发性聋的临床特点及预后分析

目的　通过分析儿童突发性聋患者的临床资料,总结其临床特点,研究影响其预后的相关因素,以指导临床诊断和治疗。方法　回顾分析2011年3月～2018年9月华中科技大学同济医学院附属荆州医院确诊并治疗的68例（71耳）儿童突发性聋患者临床资料,了解患者年龄、性别、患耳侧别、初诊时间、纯音听阈及听力曲线类型、是否伴有耳鸣和眩晕等因素对疗效的影响。结果　本组68例儿童突发性聋患者中,听力曲线类型低频下降型38.2%,高频下降型13.2%,平坦型25%,全聋型23.5%。各型总有效率（痊愈+显效+有效）分别为低频下降型84.6%,高频下降型55.6%,平坦型64.7%,全聋型31.2%。伴有耳鸣者48例（70.6%）,伴发眩晕者16例（23.5%）。经系统治疗痊愈11例（16.2%）,总有效率63.2%。多因素Logistic分析表明,听力曲线类型和初诊时间是两个独立影响儿童突发性聋预后的相关因素。结论　本组儿童突发性聋中伴发耳鸣者占多数,治疗总有效率与成人突发性聋相当。儿童突发性聋预后与听力曲线类型和初诊时间密切相关。     

鼓室内注射地塞米松治疗突聋的临床研究

目的:观察鼓室内注射地塞米松治疗突聋的临床效果。方法:对21例突聋患者采用鼓膜穿刺注入5 g/L地塞米松1 ml治疗,每日1次,7 d为1个疗程。比较地塞米松鼓室内注射前后4个频率(500、1 000、2 000、4 000 Hz)气导纯音听阈均值(PTA),下降10 dB以上为有效。结果:21例患者鼓室内注射地塞米松前后PTA分别为(65.65±24.73)dB HL和(50.25±25.59)dB HL,有明显下降,P<0.01。10例有效,11例无效,总有效率为47.6%。对发病至治疗的时间短、不伴眩晕的突聋患者应用鼓室内注射地塞米松治疗效果好。本组病例未出现鼓室内感染、鼓膜穿孔和听力下降。结论:鼓室内注射地塞米松治疗突聋安全、有效,发病至治疗的时间以及是否伴有眩晕是影响预后的因素。     

小儿突发性聋临床特征分析

目的探讨小儿突发性聋(突聋)的临床特点、疗效以及预后影响因素,指导临床治疗。方法回顾分析21例(24耳)儿童突聋患者临床资料,并与同期37例(39耳)成人突聋患者进行对比分析。结果小儿组7例有明确上呼吸道感染史,发病时伴耳鸣17耳(70.8%),伴眩晕9耳(37.5%),初诊时0.25~4kHz平均听力损失重度聋以上者23耳,占95.8%;治疗后痊愈5耳(20.8%),总有效率29.2%。成人组有上呼吸道感染史5例,占13.5%,初诊时0.25~4kHz平均听力损失重度聋以上23耳(59%),治疗后痊愈6耳(15.4%),总有效率41%。结论小儿突发性聋听力损失较成人重,预后较成人差。病毒感染可能是小儿突发性聋主要病因,初诊时听力损失水平、初诊时间与预后相关。     

言语识别率对突聋疗效评估的意义

目的：初步探讨言语识别率（word recognition score ,WRS）用于评估突聋疗效的意义。方法回顾性分析11例突聋患者的临床资料,对治疗前后的纯音听阈和言语识别率进行比较。结果11例（11耳）突聋患者治疗前、后纯音平均听阈（pure－tone average ,PTA）值分别为62．27±15．36和60．23±14．32 dB HL ,言语识别率平均值分别为42．91％±30．83％和72．73％±26．72％;治疗前后各例患者的纯音听阈及言语识别率测试声强度差异均无统计学意义（P＞0．05）,而治疗后言语识别率较治疗前明显提高,差异有统计意义（P＜0．05）。结论部分突聋患者治疗后虽然纯音听阈无改善,但言语识别率可有所提高;言语识别率可辅助纯音听阈评估突聋疗效。     

单耳听力损失患者听力障碍量表评分与纯音听阈相关性研究

目的 探讨单耳听力损失(unilateral hearing loss, UHL)患者听力障碍量表(hearing handicap inventory, HHI)评分与纯音听阈的相关性及影响因素。方法 纳入本院门诊就诊未行助听干预的UHL患者56例，听力减退病程超过1个月，好耳气导听阈<20 dB HL,差耳听阈≥35 dB HL。采用病史调查表、视觉模拟量表(visual analog scale, VAS)及听力障碍量表了解患者听力、交流障碍程度，并与纯音听阈比较，分析其特征。结果 56例患者中，伴耳鸣患者27例(48.21%),自觉伴睡眠障碍者23例(41.07%),同时患有其他慢性病者26例(46.43%)。56例好耳平均听阈为10.99±4.31 dB HL,差耳平均听阈为66.32±26.21 dB HL,HHI平均得分20.36±15.41分，VAS平均得分3.64±2.34分。纯音听阈与HHI评分、VAS评分无明显相关性(P>0.05),HHI量表得分与VAS评分的相关系数为0.77(P<0.01)。HHI量表<17分(无听力障碍)者30例占5...     

突发性聋预后影响因素

目的对影响突发性聋的预后因素进行分析讨论。方法回顾分析249例突发性聋患者临床资料,包括年龄、初诊时间,初诊时听力损失程度,听力曲线类型,是否伴有眩晕和耳鸣,进行畸变产物耳声发射(distortion product otoacoustic emissions,DPOAE)检查结果。结果初诊时间为发病后1～23天,患侧耳初诊时250 Hz～4000 Hz平均听力损失40dB以下31例(12.45%),41 dB～70 dB 80例(32.13%);71 dB～90 dB 74例(29.72%),91 dB以上64例(25.70%)。听力曲线上升型72例,下降型81例,平坦型96例。伴有眩晕96例,伴耳鸣174例。治疗药物包括血管扩张剂、皮质类固醇激素、神经营养剂、抗病毒及能量合剂,疗程2～4周。81例进行畸变耳声发射检查,45例在不同频率被引出,经治疗最终被引出DPOAE的频率听力恢复达痊愈水平。结论高龄患者和年龄小的患者预后不良;初诊时间越早听力恢复越好;听力曲线上升型预后好;伴有眩晕者预后不好;能引出DPOAE者听力恢复好。     

鼻咽癌放疗后突发性聋18例

目的 探讨鼻咽癌放疗后突发性聋(突聋)的临床特征及预后,为该类疾病的临床诊治提供依据.方法 收集并分析18例鼻咽癌放疗后突聋患者的临床资料,包括年龄、性别、耳侧、病程、伴随症状、听力曲线类型、听力损失程度、放疗后突聋发病间隔以及听力预后.结果 18例均为单侧发病,左侧10耳(55.56％),右侧8耳(44.44％);其...     

Prognostic factors for vestibular impairment in sensorineural hearing loss

The clinical course and prognosis in sensorineural hearing loss (SNHL) may be even worse if vestibular system is also involved, especially due to near location of anatomical structures in the inner ear. The aim of the study was to determine prognostic value of some clinical, audiological and demographic factors associated with SNHL in predicting a possibility of vestibular impairment. The study was conducted on 124 consecutive patients (183 ears) diagnosed for sensorineural hearing loss during 1 year in our department. In all of them, audiological (pure-tone, speech and impedance audiometry, ABR) and ENG examinations (visual ocular–motor, positional, kinetic and caloric tests) were performed. The correlations between ENG outcome and the following variables associated with sensorineural hearing loss were investigated: audiological (degree and location of hearing loss, audiogram configuration), clinical (tinnitus, vertigo, dizziness) and demographic (age, sex) factors. Normal ENG was recorded in 26.6%, vestibular impairment of peripheral type in 38.7%, and central type in 34.7% of the patients. In a multivariate stepwise linear regression analysis, the degree of hearing loss was the main variable correlating with abnormal ENG result. Tinnitus and location of hearing loss were also found to be the two other variables which, to some minor extent, can influence the ENG outcome. Peripheral vestibular impairment was observed more frequently in patients with residual hearing/deafness. The degree of hearing loss, presence of tinnitus and location of hearing loss are factors predicting the possibility of abnormal ENG outcome in sensorineural hearing loss.     

AICA syndrome with facial palsy following vertigo and acute sensorineural hearing loss

We report a case of infarction of the anterior inferior cerebellar artery (AICA) with peripheral facial palsy following vertigo and acute sensorineural hearing loss. A 39-year-old female presented with vertigo and sudden hearing loss, tinnitus, and aural fullness of the right ear. An audiogram revealed a severe hearing loss at all tested frequencies in the right ear. Spontaneous nystagmus toward the left side was also observed. Otoneurological examinations showed sensorineural hearing loss of the right ear and horizontal and rotatory gaze nystagmus toward the left side, and a caloric reflex test demonstrated canal paresis. Initially, we diagnosed the patient for sudden deafness with vertigo. However, right peripheral facial palsy appeared 2 days later. An eye tracking test (ETT) and optokinetic pattern test (OKP) showed centralis abnormality. The patient's brain was examined by magnetic resonance imaging (MRI) and magnetic resonance angioglaphy (MRA) and showed an infarction localized in the pons and cerebellum. MRI and MRA revealed infarction of the right cerebellar hemisphere indicating occlusion of the AICA. Consequently, the patient was diagnosed with AICA syndrome but demonstrated regression following steroid and edaravone treatment. We suggest that performing MRI and MRA in the early stage of AICA syndrome is important for distinguishing cerebellar infarction resulting from vestibular disease.     

影响突发性聋预后因素的临床研究

目的 研究影响突发性聋预后的相关因素,提高突发性聋预后的判断.方法 回顾性分析2006年1月至2007年3月复旦大学附属眼耳鼻喉科医院收治的突发性聋患者,首先去除初始听阈≤40 dB的低频聋患者,得到882例进行疗效分析.初始听阈＞40 dB的患者按不同的初始听阈形态与严重程度分为下坡型组(69例)、上坡型组(24例)、平坦型组(139例)、凹陷型组(44例)、极重度聋(126例)和全聋(86例)6组.结果 病程3 d内疗效最佳,其次是1、2周内,超过2周疗效差,3周内和1个月内、1个月后差异无统计学意义.病程2周内患者初始听阈＞40 dB组中凹陷型组与其他组相比预后最佳,恢复率达97.7%.极重度聋组和其他组(除全聋组)相比,治愈率(23.8%)及恢复率(57.9%)低,但好于全聋组.全聋组的预后最差,无效率达67.4%.合并有糖尿病、高血压患者的预后与其他不伴此病的患者相比差异具有统计学意义(H=4.455,P=0.0348).年龄与预后有关,年龄越大,预后也越差,以50岁为界,＜50岁的患者的预后要好于≥50岁的患者,差异有统计学意义(H=7.739,P=0.0054).结论 病程大于2周的患者疗效差,不同的初始听阈形态与听力损失程度是影响突发性聋预后的重要因素.年龄越大预后越差.合并有高血压、糖尿病的患者,其预后比无任何合并症的患者差.     

青少年突发性耳聋预后相关因素分析

目的探讨青少年突发性耳聋的临床特点、疗效及预后。方法选取65例青少年突发性耳聋病例作为研究对象,根据患者性别、患侧耳、发病季节、听力图形、听力下降程度、就诊时间、有无伴眩晕、耳鸣、吸烟饮酒史等进行分组,所得数据采用单因素秩和检验,分别比较各组治疗有效率的差异,并用logistic多元回归分析法评价各相关因素对预后的影响。结果治疗后总有效率为58.5%;单因素分析显示就诊时间、听力下降程度、有无伴眩晕等因素与预后有关(P<0.05);多因素logistic回归分析中发病至就诊时间、有无伴眩晕与预后有相关性(P<0.0 5)。结论在影响青少年突发性耳聋预后的因素中,眩晕、听力损失程度及就诊时间与预后有关。     

双耳感音神经性聋患儿合并分泌性中耳炎的临床诊治

目的 探讨双耳感音神经性聋并发分泌性中耳炎患儿的症状特点, 为及时诊治此类患者提供临床依据。方法 收集经手术治疗的双耳感音神经性聋并发分泌性中耳炎患儿(A组)17例(34耳)的病历资料, 分析其误诊原因、临床特点及并发症发生率, 并与同期行手术治疗的单纯双耳单纯分泌性中耳炎患儿(B组)17例(34耳)进行鼓室粘连发生率的比较。手术前后应用听性脑干反应(ABR)检查随诊听力变化。结果 A组均以家属发现听力下降为首诊症状, 在当地首诊曾诊断为突发性聋7例, 耳闷塞感、耳鸣、耳痛等症状叙述不清, 均无法采集到确切的分泌性中耳炎发病时间;行双耳鼓膜置管时发现中耳粘连5例(7耳), 手术前后ABR检查Ⅴ波阈值改善0～30 dB nHL, 平均17.3 dB nHL, 手术前后Ⅴ波阈值改善, 差异有统计学意义(P < 0.05)。B组患儿无1例误诊, 首诊诉耳痛或耳鸣、耳闷塞感等耳部不适症状15例, 发病时间明确, 首诊诉听力下降2例, 鼓膜置管时中耳粘连1例(1耳)。A组并发症发生率高于B组, 差异有统计学意义(P < 0.05)。结论 双耳感音神经性聋并发分泌性中耳炎患儿临床病史采集困难, 易误诊, 临床并发症发生率高, 应及时干预;鼓膜置管对听力改善效果明显。     

有眩晕及无眩晕突聋的纯音听力表现

本文分析病程２周内的特发性突聋１０９例的有眩晕及无眩晕两组病人的听力损失类型及预后。发现；女性合并眩晕多于男性，有眩晕病人平均年龄高于无眩晕病人。１０９例中深度耳聋型占４１例，平坦听力损失型３１例，高频听力损失型２５例，低频听力损失型９例，中应听力损失碟型３例。１０９例中突聋有眩晕者占４５％。     

Prognostic factors in sudden deafness

Sudden sensorineural hearing loss is still a diagnostic and therapeutic dilemma and is very difficult to predict recovery in it. Different factors may influence a prognosis like severity of hearing loss, duration of symptoms before treatment, presence of vertigo, type of audiogram and age of patients. The aim of the study was an evaluation of the hearing improvement in sudden deafness in relation to some of these elements. A retrospective analysis of 119 patients treated for sudden sensorineural hearing loss during 10 years was done. Clinical otolaryngological, neurological and ophthalmological examination, audiologic and ENG tests were carried out. Hearing improvement was obtained in 51 patients (43%). Hearing recovery was recorded in 38 patients (66%) in whom duration of disease before treatment was no longer than 7 days, in 9 patients (25%) with a period 8-14 days and in 4 patients (16%)--with period 15-30 days (66% vs 25% vs 16%, p < 0.001, 25% vs 16% p = 0.39). Hearing improvement was more frequent in patients with initially mild (51.6%) than severe (38.7%) and profound hearing loss (25%) (51.5% vs 25%, p < 0.05). Hearing recovery was observed in 18 patients (33.3%) with vertigo and in 33 patients (50.8%) without vertigo (p = 0.056). In analysis of age (five groups: until 30 years, 31-40 years, 41-50 years, 51-60 years, over 60 years) in comparison with hearing recovery it was not found any significance (45.5% vs 45.8% vs 46.4% vs 37% vs 38.9%, p = 0.94). It was stated that in patients with sudden deafness duration of the disease before treatment and level of hearing loss may significantly influence an outcome, also vertigo may worsen a recovery, contrary age of the patients does not seem as important prognostic factor.